Coherus Oncology, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
CHRS Nasdaq 2834 www.coherus.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Coherus Oncology, Inc.

Coherus Oncology (CHRS) Is Up 28.7% After ATM Offering And Bullish Coverage - What's Changed - Jan 25th, 2026 2:10 pm
Ascendis Pharma (ASND) Surges 3.0%: Is This an Indication of Further Gains? - Jan 14th, 2026 4:14 am
January 2026 Penny Stock Spotlight: Three Promising Picks - Jan 12th, 2026 5:05 am
Coherus Management to Present at the 44th Annual J.P. Morgan Healthcare Conference - Jan 6th, 2026 7:30 am
SpyGlass Pharma Appoints Jean-Frédéric Viret as Chief Financial Officer - Jan 6th, 2026 6:00 am
Coherus Oncology Announces Publication in Molecular Cancer Therapeutics Highlighting the Strong Pharmacology of Investigational CCR8 Antibody Tagmokitug (CHS-114) - Jan 5th, 2026 7:30 am
3 Promising Penny Stocks With Market Caps Under $200M - Dec 10th, 2025 11:05 am
Coherus Announces Six-Year JUPITER-02 Follow-up Results Showing LOQTORZI® plus Chemotherapy Nearly Doubles Median Overall Survival in Nasopharyngeal Carcinoma - Dec 8th, 2025 6:30 am
Coherus Oncology Presents at SITC Clinical Multiomic Biomarker Data for CHS-114, a Highly Selective anti-CCR8 Cytolytic Antibody - Nov 7th, 2025 7:00 am
Coherus Oncology Inc (CHRS) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... - Nov 6th, 2025 10:09 pm
Coherus Oncology (CHRS) Reports Q3 Loss, Lags Revenue Estimates - Nov 6th, 2025 6:15 pm
Coherus Oncology: Q3 Earnings Snapshot - Nov 6th, 2025 5:10 pm
Coherus Oncology Reports Third Quarter 2025 Financial Results and Provides Business Update - Nov 6th, 2025 2:14 pm
Arvind Sood joins Coherus Oncology as Chief Strategy and Corporate Affairs Officer - Nov 6th, 2025 11:54 am
3 Penny Stocks With Market Caps Over $80M To Consider - Nov 3rd, 2025 5:05 am
Coherus Oncology's (NASDAQ:CHRS) investors will be pleased with their solid 132% return over the last year - Nov 2nd, 2025 5:54 am
Illumina (ILMN) Beats Q3 Earnings and Revenue Estimates - Oct 30th, 2025 3:35 pm
Coherus Oncology to Report Third Quarter 2025 Financial Results on November 6, 2025 - Oct 30th, 2025 6:30 am
Coherus Oncology to Participate in Upcoming Investor Conferences - Oct 23rd, 2025 6:30 am
Coherus Oncology Announces Poster Presentation at the 40th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) - Oct 3rd, 2025 7:05 am